CYP3A4 and CYP2D6 also regulate the plasma concentrations of aripiprazole, an antipsychotic used in treating schizophrenia, and affect the symptoms and cognitive function of patients receiving risperidone [261,262]. This evidence concerns the gene CYP2D6 and schizophrenia.